2Jemal A, Murray T, Ward E, et al .Cancer statistics 2005[J ] .CA Cancer J Clin ,2005,55(1):10.
3Glimelius B, Hoffman K, Graf W ,et al .Quality of life during chemotherapy in patients with symptomatic advanced colorectal cancer.The Nordic Gastrointestinal Tumor Adjuvant Therapy Group [J ] . Cancer, 1994, 73 (3) : 556.
4Rougier P, Bugat R, Douillard J Y,et al .Phase Ⅱ study of irinotecan in the treatment of advanced colorectal cancer in chemotherapy - naive patients and patients pretreated with fluorouracil-based chemotherapy[J] .J Clin Oncol , 1997,15(1) :251.
5Cunningham D, Pyrhonen S, James RD, et al. Randomized trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal caneer[J ]. Lancet, 1998, 352 138):1 413.
6Bouche O, Raoul JL, Bonnetain F, et al .Randomized multicenter phase Ⅱ trial of a biweekly regimen of fluorouracil and Leueovorin (LV5FU2), LV5FU2 plus Cisplatin, or LVSFU2 plus Irinotecan in patients with previously untreated metastatic gastric cancer: a Federation Francophone de Cancerologie Digestive Group Study - FFCD 9803[J ] .J Clin Oncol,2004,22(21) :4 319.
7Douillard J Y, Cunningham D, Roth AD, et al. Irinotecan combined with fluorouracil compared with fluorouracil alone as first - line treatment for metastatic colorectal cancer: a muhicentre randomized trial [J] .Lancet, 2000,355(9 209) : 1 041.
8Saltz LB, Cox JV, Blanke C, et al .Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer [J ]. N Engl J Med , 2000,343(13) :905.
9Tournigand C, Andre T, Achille E, et al .FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study[J] .J Clin Oncol,2004,22(2) :229.
10Tournigand C, Andre T,Achille E,et al. FOLFIRI followed byFOLFOX6or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study[J] .J Clin Oncol,2004,22(2) :229.
